Boston Scientific has confirmed that a cyberattack is disrupting parts of its global operations, according to a filing with the U.S. Securities and Exchange Commission. The company said the incident began affecting access to key IT systems and business applications on Tuesday.
The Massachusetts-based medical technology company, known for implantable devices such as pacemakers and defibrillators, said the disruption has impacted its ability to process orders and manage shipments. An internal investigation is underway, and the timeline for full recovery remains uncertain.
Boston Scientific has not said whether patients or devices are directly affected. The company serves about 48 million patients each year, underscoring the scale of its role in global healthcare infrastructure.
The incident adds to a broader wave of cybersecurity pressure across the medical technology sector, where digital resilience is becoming as critical as product innovation. As companies strengthen their systems, the future of healthcare may depend even more on secure, connected operations.
